TNX-102 SL

cyclobenzaprine hydrochloride · Tonix Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for TNX-102 SL, covering 2014-09-26 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL) [Phase 2]

See pricing